Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
Maximilian Huttasch(Deutsches Diabetes-Zentrum e.V.), S. Kahl(Deutsches Diabetes-Zentrum e.V.), Michael Roden(Düsseldorf University Hospital)
Cited by 137
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
The integrative biology of type 2 diabetes
|Nature|2019|1.1k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789